Orion Infusion Limited (DSE:ORIONINFU)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
311.30
-6.20 (-1.95%)
At close: Apr 27, 2026
-18.21%
Market Cap 6.30B
Revenue (ttm) 665.43M
Net Income (ttm) 37.47M
Shares Out 20.36M
EPS (ttm) 1.84
PE Ratio 168.13
Forward PE n/a
Dividend 2.00 (0.64%)
Ex-Dividend Date Dec 2, 2025
Volume 257,646
Average Volume 341,983
Open 317.60
Previous Close 317.50
Day's Range 310.00 - 319.40
52-Week Range 303.30 - 587.50
Beta -1.85
RSI 32.38
Earnings Date Apr 29, 2026

About Orion Infusion

Orion Infusion Limited manufactures and sells large volume parenteral and other lifesaving injectable products in Bangladesh. The company offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; metronidazole I.V; pure steam generated fluids; and amino acids solution. It also provides sterile and nonpyrogenic solution, such as Dextrolac, Dianak, Hartman, Manisol, Plasmasol, and Proliv; hypertonic solution, including Dextrosal, Electrodex-10, Fructose – 10, Orlev, Ortac; Dextropac, an isoto... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1983
Employees 563
Stock Exchange Dhaka Stock Exchange
Ticker Symbol ORIONINFU
Full Company Profile

Financial Performance

In fiscal year 2025, Orion Infusion's revenue was 664.92 million, a decrease of -19.64% compared to the previous year's 827.42 million. Earnings were 35.02 million, a decrease of -17.27%.

Financial Statements

News

There is no news available yet.